Is CBRS a Buy? What to Consider in 2026

Short answer

The bull case for Cerebras Systems (CBRS) rests on Inference speed leadership: Cerebras positions its wafer-scale architecture as the fastest way to run large models, with independent benchmarks showing multiples of the throughput of GPU and rival inference chips on some open models. Revenue (FY2025) is ~$510M. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: Customer concentration is the defining risk: roughly 86 percent of 2025 revenue came from two UAE-affiliated buyers, and much of the future backlog now depends on a single OpenAI agreement, so the loss or renegotiation of one relationship could sharply reduce revenue. Whether CBRS is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.

Cerebras Systems (NASDAQ: CBRS) designs AI compute systems built around its Wafer-Scale Engine (WSE), a single chip the size of an entire silicon wafer with roughly 900,000 cores and large on-chip memory. That design keeps whole models in fast on-chip SRAM instead of shuttling weights to and from external memory, which lets Cerebras post very high token-generation speeds for AI inference. The company sells both on-premise systems and cloud inference capacity, positioning itself against Nvidia GPUs for large-model inference and AI supercomputing workloads. Founded in 2015 and based in Sunnyvale, California, it went public in May 2026 in one of the largest semiconductor IPOs on record. The investment picture is one of rapid growth layered over real structural risks. Full-year 2025 revenue reached about $510 million, up roughly 76 percent, and Q1 2026 core revenue of about $191 million grew around 92 percent year over year, backed by a reported remaining-performance-obligation backlog near $25 billion tied largely to a multi-year OpenAI capacity agreement. At the same time, roughly 86 percent of 2025 revenue came from two UAE-affiliated buyers (G42 and MBZUAI), gross margins are guided into the high-30s to low-40s percent, and 2025 GAAP profit was flattered by a one-time non-cash gain. With a market capitalization around $51 billion against still-modest trailing revenue, CBRS trades on future backlog conversion rather than current fundamentals.

What's the case for buying CBRS?

1. Inference speed leadership

Cerebras positions its wafer-scale architecture as the fastest way to run large models, with independent benchmarks showing multiples of the throughput of GPU and rival inference chips on some open models. As AI shifts from training toward high-volume inference, a differentiated speed advantage could expand the company's addressable market. Whether that advantage translates into durable share depends on winning workloads beyond a handful of flagship customers.

2. OpenAI and backlog conversion

A multi-year Master Relationship Agreement with OpenAI covers 750 megawatts of inference capacity valued at more than $20 billion and anchors a reported backlog near $25 billion. Revenue is described as back-half weighted in 2026 as cloud capacity comes online. Execution on building out that capacity, and OpenAI's continued commitment, are central to the growth story.

3. Diversification beyond UAE demand

Historically most revenue came from G42 and other Abu Dhabi entities, and the OpenAI deal plus a stated AWS partnership are steps toward a broader customer base. New enterprise, sovereign, and cloud customers would reduce reliance on any single buyer. Progress here is a key marker of whether Cerebras becomes a broad platform rather than a project-driven supplier.

4. Margin and profitability trajectory

Core gross margin is guided to roughly 38 to 41 percent for 2026, well below the software-like levels investors sometimes assume for AI winners. On an adjusted basis the company was still operating at a loss in 2025 once one-time items and stock compensation are removed. Scaling revenue while lifting margins is what would justify the current valuation over time.

What are the risks to CBRS?

Customer concentration is the defining risk: roughly 86 percent of 2025 revenue came from two UAE-affiliated buyers, and much of the future backlog now depends on a single OpenAI agreement, so the loss or renegotiation of one relationship could sharply reduce revenue. The valuation, a market capitalization near $51 billion on only a few hundred million dollars of trailing revenue, leaves little margin for execution stumbles or slower AI spending. Competition is intense, with Nvidia dominant and AMD, Groq, SambaNova, and in-house cloud silicon all pursuing inference. The stock is newly public and highly volatile (it has fallen sharply from its first-day highs), gross margins are modest, and 2025 GAAP profitability was inflated by a one-time non-cash gain rather than operating performance.

How is CBRS valued? (as of JULY 2026)

Price

$198.53

Market cap

$44.24B

P/E (TTM)

441.18

Forward P/E

207.40

52-week range

$160.81 to $386.34

Snapshot for CBRS as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

Revenue (FY2025): ~$510M
Revenue growth (FY2025): ~76%
Revenue (Q1 2026 core): ~$191M
Backlog / RPO: ~$25B
Market cap: ~$51B
Core gross margin (2026 guide): ~38-41%

Cerebras trades at a very high multiple of trailing revenue, reflecting expectations that its roughly $25 billion backlog, most tied to OpenAI, converts into rapid future revenue. Reported 2025 GAAP net income was inflated by a one-time non-cash gain from extinguishing a G42-related liability; on an adjusted basis the company still ran an operating loss. Investors are effectively pricing execution years ahead of current fundamentals.

How do you decide if CBRS is a buy?

Rather than asking whether CBRS is a buy in the abstract, it tends to help to answer four questions:

Thesis: do you believe the case above, and is it still true today?
Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
Overlap: check whether you already hold CBRS indirectly through an index or sector ETF before adding more.

For the full picture, see the CBRS stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about CBRS against your real portfolio and see your actual exposure before deciding.

The bottom line on CBRS

The bottom line: Cerebras Systems's story right now is Inference speed leadership, with revenue (fy2025) at ~$510M. If you believe that narrative continues, the call is about sizing CBRS sensibly and checking overlap with what you own; if you doubt it (the risk: customer concentration is the defining risk: roughly 86 percent of 2025 revenue came from two UAE-affiliated buyers, and much of the future backlog now depends on a single OpenAI agreement, so the loss or renegotiation of one relationship could sharply reduce revenue.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.

Build a basket around CBRS with Walnut

Use Cerebras Systems as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.

Create a free Walnut account

FAQ

Is CBRS a good stock to buy right now?

The case for Cerebras Systems right now is Inference speed leadership, with revenue (fy2025) at ~$510M. If you believe that thesis holds, CBRS is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is customer concentration is the defining risk: roughly 86 percent of 2025 revenue came from two UAE-affiliated buyers, and much of the future backlog now depends on a single OpenAI agreement, so the loss or renegotiation of one relationship could sharply reduce revenue. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.

What does Cerebras Systems do?

Cerebras Systems (NASDAQ: CBRS) designs AI compute systems built around its Wafer-Scale Engine (WSE), a single chip the size of an entire silicon wafer with roughly 900,000 cores a

What are the main risks of CBRS?

What does CBRS stand for?

CBRS is the Nasdaq ticker for Cerebras Systems Inc., an AI infrastructure company based in Sunnyvale, California. It is best known for its Wafer-Scale Engine, a processor built on an entire silicon wafer and designed for fast AI inference.

What does Cerebras actually sell?

Cerebras sells AI compute systems powered by its wafer-scale chips, along with cloud-based inference capacity. Customers use these to run large AI models at high speed, whether on-premise or through Cerebras cloud services, competing with racks of GPUs.

When did Cerebras go public?

Cerebras completed its IPO on Nasdaq in May 2026 under the ticker CBRS, one of the largest semiconductor IPOs on record. The stock opened well above its IPO price and has been highly volatile since, trading far below its first-day peak.

How fast is Cerebras growing?

Full-year 2025 revenue was about $510 million, up roughly 76 percent, and Q1 2026 core revenue of about $191 million grew around 92 percent year over year. Growth is supported by a large multi-year OpenAI capacity agreement.

Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell CBRS; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.